These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2199162)

  • 1. The role of class II molecules in development of insulin-dependent diabetes mellitus in mice, rats and humans.
    Acha-Orbea H; McDevitt HO
    Curr Top Microbiol Immunol; 1990; 156():103-19. PubMed ID: 2199162
    [No Abstract]   [Full Text] [Related]  

  • 2. Susceptibility to diabetes is widely distributed in normal class IIu haplotype rats.
    Ellerman KE; Like AA
    Diabetologia; 2000 Jul; 43(7):890-8. PubMed ID: 10952462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of MHC class II molecules in susceptibility to type I diabetes: identification of peptide epitopes and characterization of the T cell repertoire.
    Chao CC; Sytwu HK; Chen EL; Toma J; McDevitt HO
    Proc Natl Acad Sci U S A; 1999 Aug; 96(16):9299-304. PubMed ID: 10430937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping non-class II H2-linked loci for type 1 diabetes in nonobese diabetic mice.
    Deruytter N; Boulard O; Garchon HJ
    Diabetes; 2004 Dec; 53(12):3323-7. PubMed ID: 15561967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of insulin-dependent diabetes mellitus in nonobese diabetic mice by immunogenic but not by tolerated peptides.
    Vaysburd M; Lock C; McDevitt H
    J Exp Med; 1995 Sep; 182(3):897-902. PubMed ID: 7650494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of MHC class II molecules in the pathogenesis and prevention of Type I diabetes.
    McDevitt H
    Adv Exp Med Biol; 2001; 490():59-66. PubMed ID: 11505975
    [No Abstract]   [Full Text] [Related]  

  • 7. [Apollinaire Bouchardat Prize 2000. Immunogenetic approach to type 1 diabetes in man].
    Caillat-Zucman S
    Journ Annu Diabetol Hotel Dieu; 2000; ():39-51. PubMed ID: 10932867
    [No Abstract]   [Full Text] [Related]  

  • 8. Unaltered class II histocompatibility antigens and pathogenesis of IDDM in BB rats.
    Holowachuk EW; Greer MK
    Diabetes; 1989 Feb; 38(2):267-71. PubMed ID: 2464510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transgenic mice with I-A on islet cells are normoglycemic but immunologically intolerant.
    Böhme J; Haskins K; Stecha P; van Ewijk W; LeMeur M; Gerlinger P; Benoist C; Mathis D
    Science; 1989 Jun; 244(4909):1179-83. PubMed ID: 2499048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Major DQ8-restricted T-cell epitopes for human GAD65 mapped using human CD4, DQA1*0301, DQB1*0302 transgenic IA(null) NOD mice.
    Liu J; Purdy LE; Rabinovitch S; Jevnikar AM; Elliott JF
    Diabetes; 1999 Mar; 48(3):469-77. PubMed ID: 10078545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transgenic approaches to understanding the role of MHC genes in insulin dependent diabetes mellitus. I. Immune and non-immune mechanisms of beta cell destruction.
    Harrison LC
    Baillieres Clin Endocrinol Metab; 1991 Sep; 5(3):439-48. PubMed ID: 1909862
    [No Abstract]   [Full Text] [Related]  

  • 12. The influence of the major histocompatibility complex on development of autoimmune diabetes in RIP-B7.1 mice.
    Wong FS; Du W; Thomas IJ; Wen L
    Diabetes; 2005 Jul; 54(7):2032-40. PubMed ID: 15983204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-tolerance and differential susceptibility to diabetes in transgenic mice expressing major histocompatibility class II genes on pancreatic beta cells.
    Götz J; Eibel H; Köhler G
    Eur J Immunol; 1990 Aug; 20(8):1677-83. PubMed ID: 2209682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Major histocompatibility complex-encoded antigen processing gene polymorphism in IDDM.
    van Endert PM; Liblau RS; Patel SD; Fugger L; Lopez T; Pociot F; Nerup J; McDevitt HO
    Diabetes; 1994 Jan; 43(1):110-7. PubMed ID: 7903260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accelerated diabetes in rat insulin promoter-tumor necrosis factor-alpha transgenic nonobese diabetic mice lacking major histocompatibility class II molecules.
    Rajagopalan G; Kudva YC; Flavell RA; David CS
    Diabetes; 2003 Feb; 52(2):342-7. PubMed ID: 12540606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A peptide binding motif for I-Eg7, the MHC class II molecule that protects E alpha-transgenic nonobese diabetic mice from autoimmune diabetes.
    Gregori S; Trembleau S; Penna G; Gallazzi F; Hammer J; Papadopoulos GK; Adorini L
    J Immunol; 1999 Jun; 162(11):6630-40. PubMed ID: 10352280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proposed guidelines on screening for risk of type 1 diabetes.
    Bingley PJ; Bonifacio E; Ziegler AG; Schatz DA; Atkinson MA; Eisenbarth GS;
    Diabetes Care; 2001 Feb; 24(2):398. PubMed ID: 11213898
    [No Abstract]   [Full Text] [Related]  

  • 18. What can the HLA transgenic mouse tell us about autoimmune diabetes?
    Wong FS; Wen L
    Diabetologia; 2004 Sep; 47(9):1476-87. PubMed ID: 15349728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune diabetes can be induced in transgenic major histocompatibility complex class II-deficient mice.
    Laufer TM; von Herrath MG; Grusby MJ; Oldstone MB; Glimcher LH
    J Exp Med; 1993 Aug; 178(2):589-96. PubMed ID: 8101862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Islet cell autoimmunity in NOD mice transgenic for HLA-DQ8 and lacking I-Ag7.
    Raju R; Munn SR; Majoribanks C; David CS
    Transplant Proc; 1998 Mar; 30(2):561. PubMed ID: 9532176
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.